Tower Research Capital LLC (TRC) - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 259 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$156,583
+1025.8%
5,473
+1049.8%
0.00%
Q1 2024$13,909
-98.0%
476
-97.7%
0.00%
-100.0%
Q4 2023$692,108
+734.6%
20,513
+658.9%
0.01%
+200.0%
Q3 2023$82,928
+232.7%
2,703
+334.6%
0.00%
+200.0%
Q2 2023$24,924
+52929.8%
622
-46.1%
0.00%0.0%
Q1 2023$47
-38.2%
1,153
-41.7%
0.00%
-66.7%
Q4 2022$76
-100.0%
1,978
-45.5%
0.00%0.0%
Q3 2022$193,000
-71.7%
3,627
-69.1%
0.00%
-80.0%
Q2 2022$683,000
+11.1%
11,723
+45.6%
0.02%
+150.0%
Q1 2022$615,000
-25.2%
8,053
-41.1%
0.01%
-57.1%
Q4 2021$822,000
+1687.0%
13,666
+1560.5%
0.01%
+1300.0%
Q3 2021$46,000
-89.2%
823
-88.3%
0.00%
-90.9%
Q2 2021$427,000
+107.3%
7,045
+139.5%
0.01%
+266.7%
Q1 2021$206,000
-15.2%
2,942
-27.8%
0.00%
-57.1%
Q4 2020$243,000
+341.8%
4,072
+343.6%
0.01%
+600.0%
Q3 2020$55,000
-72.9%
918
-76.3%
0.00%
-87.5%
Q2 2020$203,000
+109.3%
3,872
+51.8%
0.01%
+14.3%
Q3 2019$97,000
+54.0%
2,551
+77.6%
0.01%
+75.0%
Q2 2019$63,000
+472.7%
1,436
+414.7%
0.00%
+300.0%
Q1 2019$11,000
+1000.0%
279
+1368.4%
0.00%
Q1 2018$1,000
-97.2%
19
-97.6%
0.00%
-100.0%
Q4 2017$36,000
-87.0%
797
-89.1%
0.01%
-78.3%
Q3 2017$276,000
+5420.0%
7,335
+7235.0%
0.02%
+2200.0%
Q2 2017$5,0000.0%100
-16.0%
0.00%
Q1 2017$5,000
-28.6%
119
-47.8%
0.00%
-100.0%
Q4 2016$7,000
-91.1%
228
-90.1%
0.00%
-87.5%
Q3 2016$79,000
-60.5%
2,313
-61.0%
0.01%
-57.9%
Q2 2016$200,000
+412.8%
5,936
+713.2%
0.02%
+216.7%
Q1 2016$39,000
+387.5%
730
+588.7%
0.01%
+500.0%
Q4 2015$8,000
-83.7%
106
-91.2%
0.00%
-80.0%
Q3 2015$49,000
+2350.0%
1,198
+4507.7%
0.01%
Q2 2015$2,000
-75.0%
26
-71.4%
0.00%
-100.0%
Q4 2014$8,000
-65.2%
91
-62.2%
0.00%
-66.7%
Q3 2014$23,000
+187.5%
241
+167.8%
0.00%
+200.0%
Q2 2014$8,000
-91.8%
90
-94.6%
0.00%
-93.8%
Q4 2013$97,000
+185.3%
1,682
+136.9%
0.02%
+300.0%
Q3 2013$34,000
+54.5%
710
-4.7%
0.00%
+100.0%
Q2 2013$22,0007450.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Doma Perpetual Capital Management LLC 1,000,761$28,631,77213.28%
GAGNON SECURITIES LLC 596,591$17,068,4693.84%
Sio Capital Management, LLC 455,500$13,031,8553.53%
Gagnon Advisors, LLC 133,390$3,816,2882.91%
AlphaCentric Advisors LLC 117,500$3,361,6752.48%
ARDSLEY ADVISORY PARTNERS LP 580,000$16,593,8002.44%
RICE HALL JAMES & ASSOCIATES, LLC 998,625$28,570,6611.71%
Lisanti Capital Growth, LLC 138,830$3,971,9260.96%
Bridge City Capital, LLC 84,856$2,427,7300.82%
Rock Springs Capital Management LP 785,000$22,458,8500.68%
View complete list of PACIRA PHARMACEUTICALS INC shareholders